Terms: = Kidney tumors AND CNOT3, KIAA0691, 4849, ENSG00000088038, O75175, NOT3H, NOT3, LENG2 AND Treatment
1 results:
1. Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study.
Tannir NM; Cho DC; Diab A; Sznol M; Bilen MA; Balar AV; Grignani G; Puente E; Tang L; Chien D; Hoch U; Choudhury A; Yu D; Currie SL; Tagliaferri MA; Zalevsky J; Siefker-Radtke AO; Hurwitz ME
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35444058
[TBL] [Abstract] [Full Text] [Related]
